Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional Results available

Pharmacokinetics and Safety of SAR441236

ClinicalTrials.gov ID: NCT03705169

Public ClinicalTrials.gov record NCT03705169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 6:25 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I, First-in-Human Study of SAR441236, a Tri-specific Broadly Neutralizing Antibody, in Participants With HIV

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of SAR441236, a tri-specific broadly neutralizing antibody against the human immunodeficiency virus (HIV).

Study identification

NCT ID
NCT03705169
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Enrollment
52 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2019 (Actual)
Primary completion
Apr 4, 2022 (Actual)
Completion
Apr 4, 2022 (Actual)
Last update posted
Jan 12, 2024

2019 – 2022

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Alabama CRS Birmingham Alabama 35294 —
UCLA CARE Center CRS Los Angeles California 90035 —
UCSD Antiviral Research Center CRS San Diego California 92103 —
Ucsf Hiv/Aids Crs San Francisco California 94110 —
University of Colorado Hospital CRS Aurora Colorado 80045 —
Northwestern University CRS Chicago Illinois 60611 —
Rush University CRS Chicago Illinois 60612 —
Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114 —
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Boston Massachusetts 02115 —
Washington University Therapeutics (WT) CRS St Louis Missouri 63110-1010 —
New Jersey Medical School Clinical Research Center CRS Newark New Jersey 07103 —
Weill Cornell Chelsea CRS New York New York 10010 —
Weill Cornell Uptown CRS New York New York 10065 —
University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester New York 14642 —
Chapel Hill CRS Chapel Hill North Carolina 27599 —
Cincinnati Clinical Research Site Cincinnati Ohio 45219 —
Case Clinical Research Site Cleveland Ohio 44106 —
Ohio State University CRS Columbus Ohio 43210 —
Penn Therapeutics, CRS Philadelphia Pennsylvania 19104 —
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213 —
The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence Rhode Island 02906 —
Vanderbilt Therapeutics (VT) CRS Nashville Tennessee 37204 —
University of Washington Positive Research CRS Seattle Washington 98104-9929 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03705169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2024 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03705169 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →